Physician profile
Grace Jeng
NPI 1952414054
$1,312.82
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $34.48 · 2021: $224 · 2022: $234 · 2023: $595 · 2024: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $710.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $710.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $359.46 | 2023 | Kxl System (Not Refurbished), Kxl1b-Ce-Marked Kxlsystem |
| Bausch & Lomb Americas INC. | $351.49 | 2022-2023 | Miebo |
| Regeneron Healthcare Solutions, INC. | $228.44 | 2019-2023 | Eylea Hd |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $223.81 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $115.14 | 2024 | Acuvue |
| Carl Zeiss Meditec, INC. | $34.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Jeng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.